Clinical Trial Update: Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating ACDN-01 for ABCA4-related Stargardt retinopathy (STELLAR) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cone Rod Dystrophy
• Stargardt Disease

Drugs mentioned

• ACDN-01

Snippet

Sponsor: Ascidian Therapeutics, Inc | Conditions: Stargardt Disease, Cone Rod Dystrophy | Phase 1, Phase 2 | Status: RECRUITING